You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Sharon Peacock, the director of COVID-19 Genomics UK, says the B.1.1.7 variant accounts for most COVID-19 cases there, according to Reuters.
The Washington Post reports on SARS-CoV-2 viral variants among immunocompromised COVID-19 patients.
In Science this week: single-cell analysis of lung alveolus formation, and more.
Bluebird Bio finds the modified virus used in its gene therapy is unlikely to be the cause of a patient's leukemia, according to Science.
The Verge looks into how the COVID-19 pandemic has accelerated the adoption of rapid at-home or point-of-care diagnostic tests.
The World Health Organization is still figuring out how to handle the pandemic a year on, the Associated Press writes.
In Nature this week: host factors that could serve as SARS-CoV-2 treatment targets, and more.
Reuters reports that a new study indicates the B.1.1.7 variant of SARS-CoV-2 is more deadly than previously circulating variants.
In a letter, former US Food and Drug Administration commissioners urge President Joe Biden to nominate a new agency head, Stat News reports.
Florida Politics reports on a proposed bill there that would require informed and written consent for collecting DNA or disclosing results of genetic analyses.
In Genome Research this week: genomic variation among peaches, possible effects of SARS-CoV-2 sequence diversity, and more.
After finding rare genetic variants that could have contributed to her children's death, a petition calls for the pardon and release of Kathleen Folbigg, the Sydney Morning Herald reports.
Rick Bright, who led the US Biomedical Advanced Research and Development Authority, is to help prevent future pandemics at the Rockefeller Foundation, Science reports.
According to the New York Times, the COVID-19 pandemic has led to fewer US Food and Drug Administration inspections of drug companies.
In PNAS this week: Neanderthals lived in Belgium until around 40,600 to 44,200 years ago, new Great Dane genome assembly, and more.
The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.
Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.
Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.
In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.
In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.
National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.
Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.
In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.
European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.
Science reports that Science Foundation Ireland is seeking annual budget increases.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.